EN
RU
Upadacitinib (CAS 2050057-56-0) is a high-purity, GMP-compliant API, a potent and selective JAK1 inhibitor (ABT-494). It treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and other autoimmune diseases. Meeting USP, EP and ICH standards, it's ideal for oral extended-release tablet formulation development and commercial production
Company Name :
Hangzhou GlobalEquipX Information Technology co.,Ltd .Brand :
GlobalEquipXCAS Number :
2050057-56-0GlobalEquipX is a professional B2B cross-border platform dedicated to the global pharmaceutical, biotech and laboratory research sectors. Our core product portfolio covers pharmaceutical stability & environmental test chambers, laboratory centrifuges, automated lab glassware washers, water purification systems, vacuum & fluid processing equipment, evaporation & concentration systems, cleanroom environment monitoring instruments, plus matched pharmaceutical raw materials and biological enzyme preparations. We also provide supporting accessories, technical support and after-sales services to meet overseas clients' one-stop procurement needs.
5908-99-6 Atropine Sulfate
1542321-58-3 Benzgalantamine Gluconate
73963-72-1 Cilostazol
1285572-51-1 Dotinurad
1229194-11-9 Edoxaban
Upadacitinib (CAS 2050057-56-0) is a high-purity, GMP-compliant API, a potent and selective JAK1 inhibitor (ABT-494). It treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and other autoimmune diseases. Meeting USP, EP and ICH standards, it's ideal for oral extended-release tablet formulation development and commercial production
Public Account
IPv6 network supported
Product categories
Technical Articles
